Northern Trust’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-102,991
Closed -$506K 4828
2021
Q3
$506K Buy
102,991
+14,876
+17% +$73.1K ﹤0.01% 3760
2021
Q2
$465K Sell
88,115
-946
-1% -$4.99K ﹤0.01% 3739
2021
Q1
$427K Buy
89,061
+20,412
+30% +$97.9K ﹤0.01% 3860
2020
Q4
$298K Sell
68,649
-2,544
-4% -$11K ﹤0.01% 3865
2020
Q3
$293K Buy
71,193
+3,277
+5% +$13.5K ﹤0.01% 3724
2020
Q2
$174K Sell
67,916
-224,801
-77% -$576K ﹤0.01% 3796
2020
Q1
$846K Buy
292,717
+7,886
+3% +$22.8K ﹤0.01% 3290
2019
Q4
$1.08M Buy
284,831
+2,285
+0.8% +$8.66K ﹤0.01% 3370
2019
Q3
$1.45M Buy
282,546
+11,116
+4% +$56.9K ﹤0.01% 3264
2019
Q2
$1.68M Buy
271,430
+586
+0.2% +$3.63K ﹤0.01% 3158
2019
Q1
$1.93M Sell
270,844
-11,441
-4% -$81.4K ﹤0.01% 3107
2018
Q4
$2.41M Sell
282,285
-4,431
-2% -$37.8K ﹤0.01% 2949
2018
Q3
$5.74M Buy
286,716
+12,153
+4% +$243K ﹤0.01% 2609
2018
Q2
$7.09M Buy
274,563
+51,508
+23% +$1.33M ﹤0.01% 2481
2018
Q1
$5.33M Buy
223,055
+25,167
+13% +$601K ﹤0.01% 2540
2017
Q4
$6.71M Buy
197,888
+2,289
+1% +$77.6K ﹤0.01% 2432
2017
Q3
$4.14M Buy
195,599
+2,327
+1% +$49.3K ﹤0.01% 2741
2017
Q2
$3.38M Sell
193,272
-10,547
-5% -$184K ﹤0.01% 2857
2017
Q1
$3.57M Buy
203,819
+4,521
+2% +$79.1K ﹤0.01% 2762
2016
Q4
$3.37M Buy
199,298
+6,945
+4% +$117K ﹤0.01% 2802
2016
Q3
$3.16M Buy
192,353
+2,753
+1% +$45.2K ﹤0.01% 2815
2016
Q2
$2.87M Buy
189,600
+50,086
+36% +$758K ﹤0.01% 2833
2016
Q1
$2.02M Buy
139,514
+19,799
+17% +$286K ﹤0.01% 2974
2015
Q4
$3.39M Sell
119,715
-620
-0.5% -$17.6K ﹤0.01% 2719
2015
Q3
$2.01M Buy
120,335
+68,406
+132% +$1.14M ﹤0.01% 3048
2015
Q2
$1.36M Buy
51,929
+13,357
+35% +$350K ﹤0.01% 3223
2015
Q1
$674K Buy
38,572
+7,031
+22% +$123K ﹤0.01% 3533
2014
Q4
$548K Sell
31,541
-358
-1% -$6.22K ﹤0.01% 3526
2014
Q3
$594K Buy
31,899
+21,403
+204% +$399K ﹤0.01% 3531
2014
Q2
$192K Buy
+10,496
New +$192K ﹤0.01% 3869